substance p has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, Q; Fu, C; Ge, C; Huang, F; Huang, H; Kang, J; Liu, L; Pearson, RB; Shi, Y; Sun, Y; Wang, X; Wu, H; Yang, T; Zhang, T; Zhou, H | 1 |
| Konwerska, A; Miskowiak, B; Nowicki, M; Ostalska-Nowicka, D | 1 |
2 other study(ies) available for substance p and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
Topics: Adult; Aged; Animals; Apoptosis; Calcium; Cell Line, Tumor; Female; Humans; Inflammation; Leukemia; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred ICR; Middle Aged; Mitochondria; Neurokinin-1 Receptor Antagonists; Oxidative Stress; Receptors, Neurokinin-1; Signal Transduction; Substance P | 2019 |
The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow.
Topics: Adolescent; B-Lymphocytes; Bone Marrow Diseases; Bone Marrow Examination; Cell Transformation, Neoplastic; Child; Child, Preschool; Disease Progression; Humans; Immunoenzyme Techniques; Immunophenotyping; In Situ Hybridization; Ki-67 Antigen; Leukemia; Leukemia, Myeloid, Acute; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Substance P | 2006 |